Detecting Pharmacovigilance Signals Combining Electronic Medical Records With Spontaneous Reports: A Case Study of Conventional Disease-Modifying Antirheumatic Drugs for Rheumatoid Arthritis
Multiple data sources are preferred in adverse drug event (ADEs) surveillance owing to inadequacies of single source. However, analytic methods to monitor potential ADEs after prolonged drug exposure are still lacking. In this study we propose a method aiming to screen potential ADEs by combining FD...
Saved in:
Main Authors: | Liwei Wang (Author), Majid Rastegar-Mojarad (Author), Zhiliang Ji (Author), Sijia Liu (Author), Ke Liu (Author), Sungrim Moon (Author), Feichen Shen (Author), Yanshan Wang (Author), Lixia Yao (Author), John M. Davis III (Author), Hongfang Liu (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2018-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Risks of malignancies related to disease-modifying antirheumatic drugs in rheumatoid arthritis: a pharmacovigilance analysis using the FAERS database
by: Wan Xiong, et al.
Published: (2024) -
Chronic Heart Failure in Early Rheumatoid Arthritis Patients Prior to Basic Antirheumatic Therapy
by: I. G. Kirillova, et al.
Published: (2020) -
Chronic Heart Failure in Rheumatoid Arthritis Patients (Part III): Effects of Antirheumatic Drugs
by: D. S. Novikova, et al.
Published: (2020) -
The impact of disease and antirheumatic therapy factors on growth retardation in children suffering from juvenile rheumatoid arthritis
by: T.M. Bzarova, et al.
Published: (2006) -
Switching and Discontinuation Pattern of Biologic Disease-Modifying Antirheumatic Drugs and Tofacitinib for Patients With Rheumatoid Arthritis in Taiwan
by: Ko-Jen Li, et al.
Published: (2021)